logo
Plus   Neg
Share
Email

Texas Industries Q3 Loss Narrows On Higher Sales

Cement producer Texas Industries Inc. (TXI) on Wednesday reported a loss for the third quarter that narrowed from last year on higher sales as construction activity in Texas and California continued to improve. Loss per share was narrower that analysts' estimates.

Cement sales for the quarter grew 26 percent to $73.09 million, as shipments and price increased. Shipments rose to 933 thousand tons from 743 thousand tons last year, while price per ton improved to $78.39 from $77.76 last year.

Stone, sand and gravel sales also improved on higher shipments as well as prices. Ready-mix concrete sales also grew on higher volumes and prices.

Texas Industries' third-quarter net loss was $5.81 million or $0.21 per share, narrower than loss of $24.28 million or $0.87 per share in the year-ago period. On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.41 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter rose 16 percent to $141.36 million from $121.89 million in the prior-year quarter. Analysts had a consensus revenue estimate for the quarter of $140.98 million.

Mel Brekhus, Chief Executive Officer of Texas Industries said, "Construction activity in Texas and California continued to improve this quarter. Gross profit increased $14.2 million on increased sales of $19.5 million."

Looking ahead, Brekhus added, "The commissioning of the second kiln at our central Texas plant is on target to be completed this spring. This additional 1.4 million tons of cement capacity, in combination with the East Texas ready mix assets we acquired last week, places TXI in a strong position to benefit from the recovery in construction that is underway."

TXI closed Wednesday's trading at $66.00, down $0.75 or 1.12 percent on a volume of 459,675 shares. However, in after-hours, the stock gained $1.50 or 2.27 percent to $67.50.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT